Literature DB >> 25624742

Focal nodular hyperplasia coexistent with hepatoblastoma in a 36-d-old infant.

Ying Gong1, Lian Chen1, Zhong-Wei Qiao1, Yang-Yang Ma1.   

Abstract

Focal nodular hyperplasia (FNH) is a benign hepatic tumor characterized by hepatocyte hyperplasia and a central stellate scar. The association of FNH with other hepatic lesions, such as adenomas, hemangiomas and hepatocellular carcinoma, has been previously reported, but FNH associated with another hepatic tumor is rare in infants. Here we report a case of FNH coexistent with hepatoblastoma in a 36-d-old girl. Computed tomography (CT) imaging showed an ill-delineated, inhomogeneous enhanced mass with a central star-like scar in the right lobe of the liver. The tumor showed early mild enhancement at the arterial phase (from 40HU without contrast to 52HU at the arterial phase), intense enhancement at the portal phase (87.7HU) and 98.1HU in the 3-min delay scan. A central scar in the tumor presented as low density on non-contrast CT and slightly enhanced at delayed contrast-enhanced scanning. This infant underwent surgical resection of the tumor. Histopathology demonstrated typical FNH coexistent with a focal hepatoblastoma, which showed epithelioid tumor cells separated by proliferated fibrous tissue.

Entities:  

Keywords:  Computed tomography; Focal nodular hyperplasia; Hepatoblastoma; Infant

Mesh:

Year:  2015        PMID: 25624742      PMCID: PMC4299321          DOI: 10.3748/wjg.v21.i3.1028

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Metastatic rectal adenocarcinoma to the liver associated with focal nodular hyperplasia.

Authors:  P J Nisar; A M Zaitoun; A Damera; Z Hodi; G M Tierney; I J Beckingham
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms.

Authors:  B N Nguyen; J F Fléjou; B Terris; J Belghiti; C Degott
Journal:  Am J Surg Pathol       Date:  1999-12       Impact factor: 6.394

3.  Focal nodular hyperplasia coexistent with hemangioma and multiple cysts of the liver.

Authors:  N Toshikuni; K Kawaguchi; H Miki; Y Kihara; T Sawayama; S Yamasaki; S Takano; T Minato
Journal:  J Gastroenterol       Date:  2001-03       Impact factor: 7.527

4.  Focal nodular hyperplasia in children, adolescents, and young adults.

Authors:  Alexander J Towbin; Guangju G Luo; Hong Yin; Jun Q Mo
Journal:  Pediatr Radiol       Date:  2010-10-15

5.  An 8-year experience of hepatic resection: indications and outcome.

Authors:  M D Finch; J L Crosbie; E Currie; O J Garden
Journal:  Br J Surg       Date:  1998-03       Impact factor: 6.939

6.  Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis.

Authors:  S-H Zhang; W-M Cong; M-C Wu
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

7.  Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome.

Authors:  Celine Icher-De Bouyn; Jerome Leclere; Graziella Raimondo; Hubert Ducou Le Pointe; Dominique Couanet; Dominique Valteau-Couanet; Olivier Hartmann
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

Review 8.  Focal nodular hyperplasia of the liver in children: review of follow-up and outcome.

Authors:  D Reymond; J Plaschkes; A R Lüthy; K Leibundgut; A Hirt; H P Wagner
Journal:  J Pediatr Surg       Date:  1995-11       Impact factor: 2.545

9.  Hemangiomas with localized nodular proliferation of the liver. A suggestion on the pathogenesis of focal nodular hyperplasia.

Authors:  O K Ndimbie; Z D Goodman; R L Chase; C K Ma; M W Lee
Journal:  Am J Surg Pathol       Date:  1990-02       Impact factor: 6.394

Review 10.  Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma.

Authors:  D M Nagorney
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.